BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23085727)

  • 1. Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD.
    Erickson KF; Lea J; McClellan WM
    Clin J Am Soc Nephrol; 2013 Jan; 8(1):75-81. PubMed ID: 23085727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
    Lea J; Greene T; Hebert L; Lipkowitz M; Massry S; Middleton J; Rostand SG; Miller E; Smith W; Bakris GL
    Arch Intern Med; 2005 Apr; 165(8):947-53. PubMed ID: 15851648
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?
    Haider DG; Masghati S; Goliasch G; Fuhrmann V; Soleiman A; Wolzt M; Baierl A; Druml W; Hörl WH
    J Nephrol; 2014 Dec; 27(6):643-51. PubMed ID: 24609889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.
    Luo S; Coresh J; Tin A; Rebholz CM; Chen TK; Hayek SS; Tracy M; Lipkowitz MS; Appel LJ; Levey AS; Inker LA; Reiser J; Grams ME
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):1013-1021. PubMed ID: 29903900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of chronic kidney disease risk categorization system in Chinese patients with kidney disease: A cohort study.
    Liu Q; Lv J; Li H; Jiao L; Yang H; Song Y; Xu G
    Nephrology (Carlton); 2015 Dec; 20(12):936-44. PubMed ID: 26032648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
    Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.
    Yi S; Contreras G; Miller ER; Appel LJ; Astor BC
    Am J Nephrol; 2009; 29(4):292-8. PubMed ID: 18824845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Metabolomic Alterations Associated with Proteinuria in CKD.
    Luo S; Coresh J; Tin A; Rebholz CM; Appel LJ; Chen J; Vasan RS; Anderson AH; Feldman HI; Kimmel PL; Waikar SS; Köttgen A; Evans AM; Levey AS; Inker LA; Sarnak MJ; Grams ME;
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):342-353. PubMed ID: 30733224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine Anion Gap to Predict Urine Ammonium and Related Outcomes in Kidney Disease.
    Raphael KL; Gilligan S; Ix JH
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):205-212. PubMed ID: 29097482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and outcomes in African Americans with CKD.
    Porter A; Fischer MJ; Wang X; Brooks D; Bruce M; Charleston J; Cleveland WH; Dowie D; Faulkner M; Gassman J; Hiremath L; Kendrick C; Kusek JW; Norris KC; Thornley-Brown D; Greene T; Lash JP;
    J Am Soc Nephrol; 2014 Aug; 25(8):1849-55. PubMed ID: 24700865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans.
    Lea J; Cheek D; Thornley-Brown D; Appel L; Agodoa L; Contreras G; Gassman J; Lash J; Miller ER; Randall O; Wang X; McClellan W;
    Am J Kidney Dis; 2008 May; 51(5):732-40. PubMed ID: 18436083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
    Bhavsar NA; Appel LJ; Kusek JW; Contreras G; Bakris G; Coresh J; Astor BC;
    Am J Kidney Dis; 2011 Dec; 58(6):886-93. PubMed ID: 21944667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.
    Lewis J; Greene T; Appel L; Contreras G; Douglas J; Lash J; Toto R; Van Lente F; Wang X; Wright JT;
    J Am Soc Nephrol; 2004 Dec; 15(12):3175-83. PubMed ID: 15579521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
    Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
    JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease.
    Norris KC; Greene T; Kopple J; Lea J; Lewis J; Lipkowitz M; Miller P; Richardson A; Rostand S; Wang X; Appel LJ
    J Am Soc Nephrol; 2006 Oct; 17(10):2928-36. PubMed ID: 16959828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans.
    Raphael KL; Wei G; Baird BC; Greene T; Beddhu S
    Kidney Int; 2011 Feb; 79(3):356-62. PubMed ID: 20962743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.
    Obi Y; Kimura T; Nagasawa Y; Yamamoto R; Yasuda K; Sasaki K; Kitamura H; Imai E; Rakugi H; Isaka Y; Hayashi T
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1558-65. PubMed ID: 20558563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study.
    DeBoer MD; Filipp SL; Musani SK; Sims M; Okusa MD; Gurka M
    Kidney Blood Press Res; 2018; 43(2):555-567. PubMed ID: 29642060
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.